A new study by an international team led by Dana-Farber Cancer Institute scientists provides the first statistically-based guidelines for determining whether a stem cell transplant is appropriate for older patients with myelodysplastic syndromes - the most common blood disorders in people over 60 years of age, and frequently a precursor for ... (more)
http://www.medilexicon.com/medicalnews.php?newsid=262405
http://www.medilexicon.com/medicalnews.php?newsid=262405
No comments:
Post a Comment